The NeoMano wearable robotic glove, available on Indiegogo, enables people recovering from stroke or living with spinal cord injuries (SCI), multiple sclerosis, cerebral palsy, or ALS to perform daily tasks they otherwise could not do on their own.

A comfortable, soft, wearable glove, NeoMano is powered by titanium wires that close wearers’ fingers so they can firmly grasp common objects with one hand.

With the NeoMano, SCI patients and others with limited hand mobility can hold a cup of coffee, grip and twist a doorknob, use a toothbrush or comb, manipulate shirt buttons and zippers, and perform other basic tasks, enabling them to more fully participate in social activities.

Neofect USA co-founder and CEO Scott Kim said: “After working with stroke patients in a rehabilitation setting, we recognized the need to improve the mobility of patients with spinal cord injuries and other forms of partial hand paralysis.

“By helping patients mimic normal hand movement, NeoMano delivers obvious physical and psychological benefits, and increases confidence. We hope this Indiegogo campaign will raise awareness of solutions that can help people with paralysis operate more independently, and expedite the development of the NeoMano so we can get it into the hands of the people who need it most.”

The NeoMano is simple to put on and use; the glove fits over a user’s index finger, middle finger, and thumb. A single press on its wireless, Bluetooth-connected controller activates the pulley housing and motor, causing the built-in titanium wires to actively close the wearer’s hand.

The button is pressed again to release the tension and return fingers to a neutral position. The robotic glove is portable, allowing users to wear it wherever they need gripping assistance, and the battery provides eight hours of continuous use.

Neofect’s line of gamified rehabilitation training solutions, including its flagship product, the RAPAEL Smart Glove for Home, delivers more engaging, measurable rehab to patients recovering from stroke and other musculoskeletal and neurological injuries. With the NeoMano, Neofect aims to support a broader base of patients, giving them the same hope, confidence, motivation, and independence it has been delivering to rehab patients for eight years.

The NeoMano devices are expected to ship in June next year.

Source: Company Press Release